# Effect of Curcumin on Systemic Lupus Erythematosus

> **NCT03953261** · PHASE2 · TERMINATED · sponsor: **Loma Linda University** · enrollment: 23 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Curcumin supplement

## Key facts

- **NCT ID:** NCT03953261
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-04-13
- **Final completion:** 2022-04-13
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** COVID and lack of support staff 2. lack of support staff to conduct the study
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953261, "Effect of Curcumin on Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03953261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*